These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4714546)

  • 41. Some aspects concerning the structure--function relationship in lipomobilizing adrenomimetics.
    Wenke M; Lincová D; Cernohorský M; Cepelík J
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):53-63. PubMed ID: 6030243
    [No Abstract]   [Full Text] [Related]  

  • 42. Lipolytic peptides in mammalian stomach and choroid plexus.
    Rudman D; Del Rio AE; Hollins B; Houser DH; Bixler TJ; Keeling ME
    Endocrinology; 1971 Apr; 88(4):901-8. PubMed ID: 4322501
    [No Abstract]   [Full Text] [Related]  

  • 43. [Investigations concerning lipolytic activity of TSH (author's transl)].
    Weisweiler P; Schwandt P
    Klin Wochenschr; 1974 May; 52(6):297-9. PubMed ID: 4409911
    [No Abstract]   [Full Text] [Related]  

  • 44. A compendium of G-protein-coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure.
    Ceddia RP; Collins S
    Clin Sci (Lond); 2020 Mar; 134(5):473-512. PubMed ID: 32149342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The gastro-entero-pancreatic hormone response to fasting in obesity.
    Andrews WJ; Henry RW; Alberti KG; Buchanan KD
    Diabetologia; 1981 Nov; 21(5):440-5. PubMed ID: 7028557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The plasma concentrations of secretin and vasoactive intestinal polypeptide (VIP) after long-term, strenuous exercise.
    Oktedalen O; Opstad PK; Schaffalitzky de Muckadell OB
    Eur J Appl Physiol Occup Physiol; 1983; 52(1):5-8. PubMed ID: 6686128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
    Prieto JC; Guerrero JM; de Miguel C; Goberna R
    Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa.
    Schwartz CJ; Kimberg DV; Sheerin HE; Field M; Said SI
    J Clin Invest; 1974 Sep; 54(3):536-44. PubMed ID: 4369434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vasoactive intestinal peptide.
    Said SI
    J Endocrinol Invest; 1986 Apr; 9(2):191-200. PubMed ID: 2872248
    [No Abstract]   [Full Text] [Related]  

  • 50. Physiological changes and gastro-intestinal symptoms as a result of ultra-endurance running.
    Rehrer NJ; Brouns F; Beckers EJ; Frey WO; Villiger B; Riddoch CJ; Menheere PP; Saris WH
    Eur J Appl Physiol Occup Physiol; 1992; 64(1):1-8. PubMed ID: 1735404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects.
    Domschke S; Domschke W; Bloom SR; Mitznegg P; Mitchell SJ; Lux G; Strunz U
    Gut; 1978 Nov; 19(11):1049-53. PubMed ID: 730072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vasoactive intestinal peptide (VIP).
    Bryant MG
    J Clin Pathol Suppl (Assoc Clin Pathol); 1978; 8():63-7. PubMed ID: 298740
    [No Abstract]   [Full Text] [Related]  

  • 53. Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture.
    Laburthe M; Rousset M; Boissard C; Chevalier G; Zweibaum A; Rosselin G
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2772-5. PubMed ID: 208077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vasoactive intestinal polypeptide promotes cyclic adenosine 3',5'-monophosphate accumulation in guinea-pig trachea.
    Frandsen EK; Krishna GA; Said SI
    Br J Pharmacol; 1978 Mar; 62(3):367-9. PubMed ID: 205290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The action of gut glucagon-like immunoreactivity and other intestinal hormones on lipolysis in chicken adipocytes.
    Langslow DR
    Horm Metab Res; 1973 Nov; 5(6):428-32. PubMed ID: 4766997
    [No Abstract]   [Full Text] [Related]  

  • 56. Lipolytic activity of synthetic (1-23) glucagon in vitro.
    Guy-Grand B; Assan R
    Horm Metab Res; 1973 Jan; 5(1):60. PubMed ID: 4706926
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of vasoactive intestinal peptide, secretin, and related peptides on rat colonic transport and adenylate cyclase activity.
    Waldman DB; Gardner JD; Zfass AM; Makhlouf GM
    Gastroenterology; 1977 Sep; 73(3):518-23. PubMed ID: 892349
    [No Abstract]   [Full Text] [Related]  

  • 58. Cations and lipolytic activity in rat adipose tissue.
    Mosinger B
    Horm Metab Res; 1970; 2():Suppl 2:71-5. PubMed ID: 4340428
    [No Abstract]   [Full Text] [Related]  

  • 59. Lipolytic action of a newly isolated vasoactive intestinal polypeptide.
    Frandsen EK; Moody AJ
    Horm Metab Res; 1973 May; 5(3):196-9. PubMed ID: 4714546
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.